| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA700695 | B | Percentage inhibition of compound against 3'-processing of HIV-1 integrase at 100 ug/mL | Human immunodeficiency virus 1 | 58 | single protein format | Scientific Literature | ||
| 2. | ALA700696 | B | Percentage inhibition against strand transfer of HIV-1 integrase at 100 ug/mL | Human immunodeficiency virus 1 | 58 | single protein format | Scientific Literature | ||
| 3. | ALA701808 | B | Inhibitory concentration of compound against 3' processing of HIV-2 integrase | Human immunodeficiency virus 2 | 1 | single protein format | Scientific Literature | ||
| 4. | ALA699437 | B | Inhibitory concentration of compound against strand transfer of HIV- integrase | Human immunodeficiency virus 2 | 1 | single protein format | Scientific Literature | ||
| 5. | ALA697789 | B | Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 1 | Human immunodeficiency virus 1 | 37 | single protein format | Scientific Literature | ||
| 6. | ALA701792 | B | Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 2 | Human immunodeficiency virus 1 | 35 | single protein format | Scientific Literature | ||
| 7. | ALA699508 | B | Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1 | Human immunodeficiency virus 1 | 37 | single protein format | Scientific Literature | ||
| 8. | ALA699510 | B | Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 2 | Human immunodeficiency virus 1 | 35 | single protein format | Scientific Literature | ||
| 9. | ALA3231232 | B | Inhibition of ribonucleotide reductase purified from rat Novikoff hepatoma assessed as inhibition of [3H]CDP to [3H]dCDP conversion after 40 mins | Rattus norvegicus | 18 | assay format | Scientific Literature | ||
| 10. | ALA3231234 | F | Antitumor activity against mouse L1210 cells allografted in C6D2F1 mouse at 10 to 1000 mg/kg, ip for 8 days starting from day 1 of challenge relative to control | Mus musculus | 18 | organism-based format | Scientific Literature | ||
| 11. | ALA3231235 | F | Antitumor activity against ip dosed mouse L1210 cells allografted in C6D2F1 mouse assessed as dose to achieve maximum life span administered for 8 days starting from day 1 of challenge | Mus musculus | 17 | organism-based format | Scientific Literature | ||
| 12. | ALA3231236 | F | Antitumor activity against mouse L1210 cells allografted in C6D2F1 mouse at 139 mg/kg, ip bid at interval of 1 hr between each dosing for 8 days starting from day 1 of challenge relative to control | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 13. | ALA3231237 | F | Antitumor activity against mouse L1210 cells allografted in C6D2F1 mouse at 139 mg/kg, ip bid at interval of 3 hrs between each dosing for 8 days starting from day 1 of challenge relative to control | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 14. | ALA3231238 | F | Antitumor activity against mouse L1210 cells allografted in C6D2F1 mouse at 139 mg/kg, ip bid at interval of 5 hrs between each dosing for 8 days starting from day 1 of challenge relative to control | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 15. | ALA3231239 | F | Antitumor activity against mouse L1210 cells allografted in C6D2F1 mouse at 139 mg/kg, ip bid at interval of 7 hrs between each dosing for 8 days starting from day 1 of challenge relative to control | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 16. | ALA3231240 | F | Antitumor activity against mouse L1210 cells allografted in C6D2F1 mouse at 200 mg/kg, ip for 8 days starting from day 1 of challenge relative to control | Mus musculus | 4 | organism-based format | Scientific Literature | ||
| 17. | ALA3231247 | F | Antitumor activity against mouse L1210 cells allografted in C6D2F1 mouse at 100 mg/kg, ip for 8 days starting from day 1 of challenge relative to control | Mus musculus | 2 | organism-based format | Scientific Literature | ||
| 18. | ALA3231248 | F | Antitumor activity against mouse L1210 cells allografted in C6D2F1 mouse at 400 mg/kg, ip for 8 days starting from day 1 of challenge relative to control | Mus musculus | 2 | organism-based format | Scientific Literature | ||
| 19. | ALA3231249 | F | Antitumor activity against mouse L1210 cells allografted in C6D2F1 mouse at 800 mg/kg, ip for 8 days starting from day 1 of challenge relative to control | Mus musculus | 2 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!